NO20010203D0 - Diacylhydrazinderivater som integrininhibitorer - Google Patents
Diacylhydrazinderivater som integrininhibitorerInfo
- Publication number
- NO20010203D0 NO20010203D0 NO20010203A NO20010203A NO20010203D0 NO 20010203 D0 NO20010203 D0 NO 20010203D0 NO 20010203 A NO20010203 A NO 20010203A NO 20010203 A NO20010203 A NO 20010203A NO 20010203 D0 NO20010203 D0 NO 20010203D0
- Authority
- NO
- Norway
- Prior art keywords
- integrin inhibitors
- diacylhydrazine derivatives
- diacylhydrazine
- derivatives
- integrin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
- C07D271/113—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
- C07C281/06—Compounds containing any of the groups, e.g. semicarbazides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19831710A DE19831710A1 (de) | 1998-07-15 | 1998-07-15 | Diacylhydrazinderivate |
| PCT/EP1999/004673 WO2000003973A1 (de) | 1998-07-15 | 1999-07-06 | Diacylhydrazinderivate als integrin-inhibitoren |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20010203D0 true NO20010203D0 (no) | 2001-01-12 |
| NO20010203L NO20010203L (no) | 2001-01-12 |
Family
ID=7874107
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20010203A NO20010203L (no) | 1998-07-15 | 2001-01-12 | Diacylhydrazinderivater som integrininhibitorer |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6326403B1 (no) |
| EP (1) | EP1097127B1 (no) |
| JP (1) | JP2002520382A (no) |
| KR (1) | KR20010079520A (no) |
| CN (1) | CN1309633A (no) |
| AR (1) | AR019777A1 (no) |
| AT (1) | ATE234276T1 (no) |
| AU (1) | AU753333B2 (no) |
| BR (1) | BR9912072A (no) |
| CA (1) | CA2337305A1 (no) |
| DE (2) | DE19831710A1 (no) |
| DK (1) | DK1097127T3 (no) |
| ES (1) | ES2194486T3 (no) |
| HU (1) | HUP0102602A3 (no) |
| ID (1) | ID27168A (no) |
| NO (1) | NO20010203L (no) |
| PL (1) | PL345398A1 (no) |
| PT (1) | PT1097127E (no) |
| SK (1) | SK412001A3 (no) |
| TW (1) | TW448145B (no) |
| WO (1) | WO2000003973A1 (no) |
| ZA (1) | ZA200101267B (no) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| YU85501A (sh) | 1999-06-01 | 2004-07-15 | Biogen Inc. | Upotreba blokirajućeg monoklonalnog antitela za vla-1 za pripremanje farmaceutskog preparata za tretiranje inflamatornih poremećaja |
| US20020002152A1 (en) | 2000-04-14 | 2002-01-03 | Craig Richard A. | Hydrazide and alkoxyamide angiogenesis inhibitors |
| UY26664A1 (es) * | 2000-04-14 | 2001-11-30 | Abbott Lab | Hidrazidas y alcoxiamidas inhibidoras de la angiogénesis. |
| DE10040103A1 (de) | 2000-08-17 | 2002-02-28 | Merck Patent Gmbh | Peptid- und Peptidmimetika-Derivate mit Integrin-Inhibitor-Eigenschaften II |
| DE10040105A1 (de) | 2000-08-17 | 2002-02-28 | Merck Patent Gmbh | Peptid- und Peptidmimetika-Derivate mit Integrin-Inhibitor-Eigenschaften |
| DZ3415A1 (fr) * | 2000-08-31 | 2002-03-07 | Chiron Corp | Guanidinobenzamides comme mc4-r agonistes. |
| EP1767525A1 (en) | 2001-04-09 | 2007-03-28 | Novartis Vaccines and Diagnostics, Inc. | Guanidino compounds as melanocortin-4 receptor (MC4-R) agonists |
| CZ303450B6 (cs) * | 2001-04-13 | 2012-09-19 | Biogen Idec Ma Inc. | Protilátky k VLA-1, kompozice je obsahující a nukleové kyseliny, které je kódují, zpusob stanovení hladiny VLA-1 a použití pri lécení imunologického onemocnení |
| ATE478867T1 (de) | 2002-05-23 | 2010-09-15 | Novartis Vaccines & Diagnostic | Substituierte quinazolinone verbindungen |
| US7226577B2 (en) | 2003-01-13 | 2007-06-05 | Bracco Imaging, S. P. A. | Gastrin releasing peptide compounds |
| US7304161B2 (en) * | 2003-02-10 | 2007-12-04 | Intrexon Corporation | Diaclhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex |
| US7456315B2 (en) * | 2003-02-28 | 2008-11-25 | Intrexon Corporation | Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| KR20060018217A (ko) | 2003-05-23 | 2006-02-28 | 카이론 코포레이션 | Ｍｃ4-ｒ 작용제로서 구아니디노-치환된 퀴나졸리논 화합물 |
| DE10325049A1 (de) * | 2003-06-02 | 2004-12-23 | Merck Patent Gmbh | Peptid- und Peptidmimetika-Derivate mit Integrin-Inhibitor-Eigenschaften III |
| KR20060105785A (ko) | 2003-11-19 | 2006-10-11 | 카이론 코포레이션 | 감소된 생체축적을 갖는 퀴나졸리논 화합물 |
| CA2568750C (en) | 2004-06-04 | 2014-05-27 | The Scripps Research Institute | Compositions and methods for treatment of neovascular diseases |
| JP4745175B2 (ja) * | 2005-12-28 | 2011-08-10 | 本田技研工業株式会社 | 自動二輪車 |
| BRPI0712607A8 (pt) * | 2006-05-25 | 2019-06-04 | Biogen Idec Inc | métodos de tratamento de acidente vascular cerebral |
| CN104761466A (zh) * | 2007-05-29 | 2015-07-08 | 英特拉克森公司 | 通过蜕皮素受体复合物调节外源性基因表达的手性二酰基肼配体 |
| CN104271122A (zh) | 2012-02-16 | 2015-01-07 | 桑塔鲁斯股份有限公司 | 抗vla1(cd49a)抗体药物组合物 |
| DK2970106T3 (en) | 2013-03-15 | 2018-08-13 | Intrexon Corp | CONTAINING DIACYL HYDRAZINES |
| RU2016146826A (ru) | 2014-05-30 | 2018-07-04 | Пфайзер Инк. | Производные карбонитрилов как селективные модуляторы андрогенового рецептора |
| CN104027805B (zh) * | 2014-06-18 | 2017-02-15 | 北京大学 | 抑制整合素α5的物质在制备预防内皮细胞激活和/或动脉粥样硬化的产品中的新用途 |
| AU2015317862A1 (en) | 2014-09-17 | 2017-04-06 | Intrexon Corporation | Boron-containing diacylhydrazine compounds |
| JP7445594B2 (ja) | 2017-11-01 | 2024-03-07 | アローヘッド ファーマシューティカルズ インコーポレイテッド | インテグリンリガンドおよびその使用 |
| WO2023275715A1 (en) | 2021-06-30 | 2023-01-05 | Pfizer Inc. | Metabolites of selective androgen receptor modulators |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5051405A (en) * | 1989-10-10 | 1991-09-24 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Anti-thrombotic peptides and pseudopeptides |
| WO1992013552A1 (en) * | 1991-02-05 | 1992-08-20 | Smithkline Beecham Corporation | Anti-aggregatory peptides containing an aromatic ester or amide |
| US5530028A (en) * | 1992-11-23 | 1996-06-25 | Rohm And Haas Company | Insecticidal N'-substituted-N,N'-diacylhydrazines |
| WO1994014775A1 (en) * | 1992-12-29 | 1994-07-07 | Smithkline Beecham Corporation | Platelet aggregation inhibiting compounds |
| US5741796A (en) | 1994-05-27 | 1998-04-21 | Merck & Co., Inc. | Pyridyl and naphthyridyl compounds for inhibiting osteoclast-mediated bone resorption |
| US5482962A (en) * | 1994-07-22 | 1996-01-09 | Rohm And Haas Company | Insecticidal N,N'-disubstituted-N-N'-diacylhydrazines |
| WO1997026250A1 (en) * | 1996-01-16 | 1997-07-24 | Merck & Co., Inc. | Integrin receptor antagonists |
-
1998
- 1998-07-15 DE DE19831710A patent/DE19831710A1/de not_active Withdrawn
-
1999
- 1999-07-06 JP JP2000560082A patent/JP2002520382A/ja active Pending
- 1999-07-06 WO PCT/EP1999/004673 patent/WO2000003973A1/de not_active Application Discontinuation
- 1999-07-06 ES ES99934576T patent/ES2194486T3/es not_active Expired - Lifetime
- 1999-07-06 PL PL99345398A patent/PL345398A1/xx unknown
- 1999-07-06 ID IDW20010206A patent/ID27168A/id unknown
- 1999-07-06 BR BR9912072-0A patent/BR9912072A/pt not_active IP Right Cessation
- 1999-07-06 KR KR1020017000359A patent/KR20010079520A/ko not_active Application Discontinuation
- 1999-07-06 HU HU0102602A patent/HUP0102602A3/hu unknown
- 1999-07-06 CN CN99808610A patent/CN1309633A/zh active Pending
- 1999-07-06 US US09/743,605 patent/US6326403B1/en not_active Expired - Fee Related
- 1999-07-06 AU AU50313/99A patent/AU753333B2/en not_active Ceased
- 1999-07-06 AT AT99934576T patent/ATE234276T1/de not_active IP Right Cessation
- 1999-07-06 DK DK99934576T patent/DK1097127T3/da active
- 1999-07-06 EP EP99934576A patent/EP1097127B1/de not_active Expired - Lifetime
- 1999-07-06 SK SK41-2001A patent/SK412001A3/sk unknown
- 1999-07-06 DE DE59904547T patent/DE59904547D1/de not_active Expired - Fee Related
- 1999-07-06 PT PT99934576T patent/PT1097127E/pt unknown
- 1999-07-06 CA CA002337305A patent/CA2337305A1/en not_active Abandoned
- 1999-07-13 TW TW088111860A patent/TW448145B/zh active
- 1999-07-14 AR ARP990103436A patent/AR019777A1/es not_active Application Discontinuation
-
2001
- 2001-01-12 NO NO20010203A patent/NO20010203L/no not_active Application Discontinuation
- 2001-02-14 ZA ZA200101267A patent/ZA200101267B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR019777A1 (es) | 2002-03-13 |
| BR9912072A (pt) | 2001-09-25 |
| AU753333B2 (en) | 2002-10-17 |
| AU5031399A (en) | 2000-02-07 |
| CA2337305A1 (en) | 2000-01-27 |
| ES2194486T3 (es) | 2003-11-16 |
| ZA200101267B (en) | 2002-10-04 |
| PT1097127E (pt) | 2003-07-31 |
| DE19831710A1 (de) | 2000-01-20 |
| JP2002520382A (ja) | 2002-07-09 |
| HUP0102602A3 (en) | 2002-02-28 |
| TW448145B (en) | 2001-08-01 |
| EP1097127B1 (de) | 2003-03-12 |
| HUP0102602A2 (hu) | 2002-01-28 |
| NO20010203L (no) | 2001-01-12 |
| ID27168A (id) | 2001-03-08 |
| PL345398A1 (en) | 2001-12-17 |
| DE59904547D1 (de) | 2003-04-17 |
| EP1097127A1 (de) | 2001-05-09 |
| ATE234276T1 (de) | 2003-03-15 |
| DK1097127T3 (da) | 2003-06-10 |
| CN1309633A (zh) | 2001-08-22 |
| KR20010079520A (ko) | 2001-08-22 |
| US6326403B1 (en) | 2001-12-04 |
| WO2000003973A1 (de) | 2000-01-27 |
| SK412001A3 (en) | 2001-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1097127T3 (da) | Diacylhydrazinderivater som integrininhibitorer | |
| DK1244647T3 (da) | Quinzolinderivater som VIGF-inhibitorer | |
| DK2253620T3 (da) | Substituerede 3-cyanoquinoliner som protein-tyrosinkinase-inhibitorer | |
| NO986090D0 (no) | Fenylalaninderivater som integrininhibitorer | |
| NO992725D0 (no) | 6-Fenylpyridyl-2-amin-derivater anvendelige som NOS-inhibitorer | |
| ATE245142T1 (de) | No-synthase inhibitoren | |
| NO20021239D0 (no) | Pteridinoner som kinase-inhibitorer | |
| NO20010193D0 (no) | Tiobenzimidazol-derivater | |
| DK0930302T3 (da) | Benzosulfonderivater | |
| DE69942123D1 (de) | FACTOR VIIa INHIBITORE | |
| NO20015065D0 (no) | Pyrazolobenzodiazepiner som CDK2-inhibitorer | |
| NO20010514L (no) | Aminometylkarboksylsyre-derivater | |
| ATE259810T1 (de) | Phenyl-xanthinderivate | |
| NO20021407D0 (no) | Bifenylderivater anvendt som NHE-3-inhibitorer | |
| ATE252547T1 (de) | Matrixmetalloproteinaseinhibitoren | |
| NO20023001D0 (no) | Substituerte piperazinderivater som MTP inhibitorer | |
| NO20011512L (no) | 2-Fenylpyran-4-on derivater | |
| ATE233253T1 (de) | Chromanderivate | |
| DK1134219T3 (da) | Cucloalkylsubstituerede aminomethylpyrrolidinderivater | |
| ATE249427T1 (de) | Diacylhydrazinderivate | |
| DK1060183T3 (da) | 5-deoxycytidinderivater | |
| ATE240308T1 (de) | Sulfonamid-derivate | |
| NO20011654L (no) | Benzamidderivater som trombininhibitorer | |
| NO20000094D0 (no) | 6-Azaurcilderivater som IL-5 inhibitorer | |
| DE59907635D1 (de) | Pyrazolyldioxothiochromanoyl-derivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |